Regulation of eNOS Expression in Brain Endothelial Cells by Perinuclear EP3 Receptors

doi:10.1161/01.RES.0000013303.17964.7A

Paper

Regulation of eNOS Expression in Brain Endothelial Cells by Perinuclear EP3 Receptors

Published Apr 5, 2002 · F. Gobeil, I. Dumont, A. M. Marrache

Circulation Research: Journal of the American Heart Association

Q1 SJR score

129

Citations

5

Influential Citations

Full textSemantic Scholar

Abstract

We reported upregulation of endothelial nitric oxide synthase (eNOS) by PGE2 in tissues and presence of perinuclear PGE2 receptors (EP). We presently studied mechanisms by which PGE2 induces eNOS expression in cerebral microvessel endothelial cells (ECs). 16,16-Dimethyl PGE2 and selective EP3 receptor agonist M&B28767 increased eNOS expression in ECs and the NO-dependent vasorelaxant responses induced by substance P on cerebral microvessels. These effects could be prevented by prostaglandin transporter blocker bromcresol green and actinomycin D. EP3 immunoreactivity was confirmed on plasma and perinuclear membrane of ECs. M&B28767 increased eNOS RNA expression in EC nuclei, and this effect was augmented by overexpression of EP3 receptors. M&B28767 also induced increased phosphorylation of Erk-1/2 and Akt, as well as changes in membrane potential revealed by the potentiometric fluorescent dye RH421, which were prevented by iberiotoxin; perinuclear KCa channels were detected, and their functionality corroborated by NS1619-induced Ca2+ signals and nuclear membrane potential changes. Moreover, pertussis toxin, Ca2+ chelator, and channel blockers EGTA, BAPTA, and SK&F96365, as well as KCa channel blocker iberiotoxin, protein-kinase inhibitors wortmannin and PD 98059, and NF-&kgr;B inhibitor pyrrolidine dithiocarbamate prevented M&B28767-induced increase in Ca2+ transients and/or eNOS expression in EC nuclei. We describe for the first time that PGE2 through its access into cell by prostaglandin transporters induces eNOS expression by activating perinuclear EP3 receptors coupled to pertussis toxin-sensitive G proteins, a process that depends on nuclear envelope KCa channels, protein kinases, and NF-&kgr;B; the roles for nuclear EP3 receptors seem different from those on plasma membrane.

In Vitro Study

Highly Cited

Study Snapshot

PGE2 induces eNOS expression in brain endothelial cells by activating perinuclear EP3 receptors, a process involving nuclear envelope KCa channels, protein kinases, and NF-B.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Paper

Regulation of eNOS Expression in Brain Endothelial Cells by Perinuclear EP3 Receptors

Sign up to use Study Snapshot

References

Phosphatidylinositol 3‐kinase and ERK are required for NF‐κB activation but not for phagocytosis

PI3K and ERK are essential for NFB activation in monocytes, but not for phagocytosis, suggesting their role in gene activation but not phagocytosis.

Up-regulation of Endothelial Nitric-oxide Synthase Promoter by the Phosphatidylinositol 3-Kinase γ/Janus Kinase 2/MEK-1-dependent Pathway*

Lysophosphatidylcholine (LPC) enhances endothelial nitric oxide synthase promoter activity through a novel, pertussis toxin-sensitive pathway, PI-3K/Jak2/MEK-1/ERK1/2.

Prolonged Hypercapnia-Evoked Cerebral Hyperemia via K+ Channel– and Prostaglandin E2–Dependent Endothelial Nitric Oxide Synthase Induction

Prolonged hypercapnia increases cerebral blood flow through the induction of endothelial nitric oxide synthase, which can be blocked by cyclooxygenase inhibitors and NOS inhibitors.

Protein kinases as mediators of phosphoinositide 3-kinase signaling.

PI3K signaling plays a crucial role in cell growth, differentiation, insulin action, and cell survival, and its activity may be linked to various human diseases.

The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs.

Recombinant human prostanoid receptors allow for the first time to assess the affinity and selectivity of novel compounds at individual human prostanoid receptors, aiding in pharmacological studies and understanding prostanoid receptor biology.

Citations